SCHEMBL13894574

SCHEMBL13894574

ICc1nc(-c2ccccc2)ns1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.53
ADORA2A P29274 1/20 0.53
ADORA2B P29275 1/20 0.53
ADORA1 P30542 1/20 0.53
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
SMN1; SMN2 Q16637 5/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
AKR1B1 P15121 1/20 0.42
LMNA P02545 3/20 0.41
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5018814 0.81 ADORA3 (0.58) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL12297061 0.81 ADORA3 (0.53) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL12912144 0.77 ADORA3 (0.49) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL4414559 0.77 AKR1B1 (0.57) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL1613977 0.77 ADORA3 (0.49) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL1272257 0.74 ADORA3 (0.50) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL1613976 0.74 AKR1B1 (0.49) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL2011938 0.74 ADORA3 (0.50) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL1272255 0.74 ADORA3 (0.46) ADORA3ADORA2AADORA2BADORA1NPC1
SCHEMBL930343 0.74 ADORA3 (0.59) ADORA3ADORA2AADORA2BADORA1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009055357-A1 DIAZEPANE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-30 WO disclosed